Zusammenfassung
Bei den Knochentumoren ist die vollständige operative Resektion die Lokaltherapie der Wahl. Nur bei Ewing-Tumoren kann mit definitiver Radiotherapie und konventionellen Bestrahlungsdosen eine hohe lokale Kontrolle erzielt werden. Alle weiteren Knochentumoren benötigen zur lokalen Kontrolle eine hohe Strahlendosis, die vielfach mit konventionellen Bestrahlungstechniken nicht erzielt werden kann. Hier kommen Spezialtechniken wie z. B. die Protonentherapie zum Einsatz, die die Applikation entsprechender Bestrahlungsdosen erlauben und damit den lokalen Effekt der Bestrahlung verbessern können.
Abstract
In bone sarcoma, the local treatment of choice is complete surgical resection. Only in Ewing tumors does definitive radiotherapy with conventional radiation doses achieve satisfactory local control rates. All other bone tumors need very high radiation doses, which often cannot be obtained with conventional radiotherapy. In such cases, special techniques, such as proton therapy, which allow the application of very high doses to the target are frequently used.
Literatur
Abenoza P, Sibley RK (1986) Chordoma: an immunohistologic study. Hum Pathol 17:744–747
Anderson PM, Wiseman GA, Disenzieri A et al. (2002) High-dose samarium-153 ethylene diamine tetramethylene phosphonate: Low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases. J Clin Oncol 20:189–196
Arai Y, Kun LE, Brooks T et al. (1991) Ewing‘s Sarcoma: Local tumor control and patterns of failure following limited volume radiation therapy. Int J Radiat Oncol Biol Phys 21:1501–1508
Austin JP, Urie MM, Cardenosa G et al. (1993) Probable causes of recurrence in patients with chordoma and chondrosarcoma of the base of skull and cervical spine. Int J Radiat Oncol Biol Phys 25:439–444
Bielack SS, Kempf-Bielack B, Delling G et al. (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20:776–790
Burkey BB, Hoffman HT, Baker SR et al. (1990) Chondrosarcoma of the head and neck. Laryngoscope 100:1301–1305
Calvo FA, de Urbina DO, Sierrasesumaga L et al. (1991) Intraoperative radiotherapy in the multidisciplinary treatment of bone sarcomas in children and adolescents. Med Pediatr Oncol 19:478–485
Colli BO, Al-Mefty O (2001) Chordomas of the craniocervical junction: follow-up review and prognostic factors. J Neurosurg 95:933–943
Dahlin DC, McCarthy CS (1952) Chordoma: A study of 59 cases. Cancer 5:1170–1178
DeLaney TF, Park L, Goldberg SI et al. (2005) Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys 61:492–498
Debus J, Schulz-Ertner D, Schad L et al. (2000) Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys 47:591–596
Dickey ID, Rose PS, Fuchs B et al. (2004) Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. J Bone Joint Surg 86A (11):2412–2418
Dincbas F, Koca S, Mandel NM et al. (2005) The role of preoperative radiotherapy in nonmetastatic high-grade osteosarcoma of the extremities for limb-sparing surgery. Int J Radiat Oncol Biol Phys 62:820–828
Donaldson S, Torrey M, Link M et al. (1998) A multidisciplinary study investigating radiotherapy in Ewing’s sarcoma: End results of POG #8346. Int J Radiat Oncol Biol Phys 42:125–135
Dunst J, Jürgens H, Sauer R et al. (1995) Radiation therapy in Ewing’s Sarcoma: An update of the CESS 86 trial. Int J Radiat Oncol Biol Phys 32:919–930
Eilber F, Giuliano A, Eckardt J et al. (1987) Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol 5:21–26
Franzius C, Bielack S, Flege S (2001) High-activity samarium-153-EDTMP therapy followed by autologous peripheral blood stem cell support in unresectable osteosarcoma. Nuklearmedizin 40:215–220
Fuchs N, Bielack SS, Epler D et al. (1998) Long-term results of the co-operative German-Austrian-Swiss Osteosarcoma Study Group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 9:893–899
Haberer T, Becher W, Schardt D et al. (1993) Magnetic scanning system for heavy ion therapy. Nucl Instr Meth Phys Res 330:296–305
Hassounah M, Al-Mefty O, Akhtar M et al. (1985) Primary cranial and intracranial chondrosarcoma. A survey. Acta Neurochir (Wien) 78:123–132
Hug EB, Loredo LN, Slater JD et al. (1999) Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 91:432–439
Huvos AG, Marcove RC (1987) Chondrosarcoma in the young. A clinicopathologic analysis of 79 patients younger than 21 years of age. Am J Surg Pathol 11:930–942
Jäkel O, Krämer M, Karger CP (2001) Treatment planning for heavy ion radiotherapy: clinical implementation and application. Phys Med Biol 46:1101–1116
Jeffree GM, Price CH, Sissons HA (1975) The metastatic patterns of osteosarcoma. Br J Cancer 32:87–107
Kamada T, Tsujii H, Tsuji H et al. (2002) Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol 20:4466–4471
Karger CP, Schulz-Ertner D, Didinger B et al. (2003) Influence of setup errors on spinal cord dose and treatment plan quality for cervical spine tumours: a phantom study for photon IMRT and heavy charged particle radiotherapy. Phys Med Biol 48:3171–3189
Koch BB, Karnell LH, Hoffman HT et al. (2000) National cancer database report on chondrosarcoma of the head and neck. Head Neck 22:408–425
Könemann S, Deppe K, Schuck A et al. (2002) Fractionated perioperative high dose rate brachytherapy using a tissue equivalent bendy applicator. Br J Radiol 75:453–459
Korten AGGC, ter Berg HJW, Spincemaille GH et al. (1998) Intracranial chondrosarcoma: review of the literature and report of 15 cases. J Neurol Neurosurg Psychiatry 65:88–92
Kraft G, Kraft-Weyrather W, Ritter S et al. (2000) Cellular and subcellular effect of heavy ions: a comparison of the induction of strand breaks and chromosomal aberration with the incidence of inactivation and mutation. Adv Space Res 9:59–72
Link MP (1993) The multi-institutional osteosarcoma study: an update. Cancer Treat Res 62:261–267
Machak GN, Tkachev SI, Solovyev YN et al. (2003) Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities. Mayo Clin Proc 78:147–155
Merchant T, Zelefsky M, Sheldon J, LaQuaglia M, Harrison L (1998) High-dose rate intraoperative radiation therapy for pediatric solid tumors. Med Ped Oncol 30:34–39
Müller RP, Wannenmacher M, Rieck K, Schnepper E (1980) Beitrag zur Strahlentherapie der Chordome anhand eigener Fälle und im Vergleich der Literatur. Strahlentherapie 156:92–96
Munzenrider JE, Liebsch NJ (1999) Proton therapy for tumors of the skull base. Strahlenther Onkol 175 [Suppl II]:57–63
Noel G, Habrand JL, Jauffret E et al. (2003) Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and pattern of failure. Strahlenther Onkol 179:241–248
Ogata T, Teshima T, Kagawa K et al. (2005) Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res 65:113–120
Ozaki T, Flege S, Liljenqvist U et al. (2002) Osteosarcoma of the spine. Cancer 94:1069–1077
Ozaki T, Flege S, Kevric M et al. (2005) Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol 21:334–341
Paulussen M, Ahrens S, Burdach S et al. (1998) Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from the EICESS studies. Ann Oncol 9:275–281
Paulussen M, Poremba C, Schuck A, Winkelmann W, Dunst J, Jürgens H (2001) Behandlungskonzept des Ewing-Tumors. Onkologe 7:428–437
Romero J, Cardenes H, la Torre A et al. (1993) Chordoma: results of radiation therapy in eighteen patients. Radiother Oncol 29:27–32
Sailer S, Harmon D, Mankin H, Truman J, Suit H (1988) Ewing’s sarcoma: surgical resection as a prognostic factor. Int J Radiat Oncol Biol Phys 15:43–52
Schoenthaler R, Castro JR, Petti PL et al. (1993) Charged particle irradiation of sacral chordomas. Int J Radiat Oncol Biol Phys 26:291–298
Schuck A, Hofmann J, Rübe C et al. (1998) Radiotherapy in Ewing’s sarcoma and PNET of the chest wall: Results of the trials CESS 81, CESS 86 and EICESS 92. Int J Radiat Oncol Biol Phys 42:1001–1006
Schuck A, Ahrens S, Paulussen M et al. (2003) Local therapy in localized Ewing tumors: Results of 1.058 patients treated in the CESS 81, CESS 86 and EICESS 92 trials. Int J Radiat Oncol Biol Phys 55:168–177
Schulz-Ertner D, Nikoghosyan A, Thilmann C et al. (2004) Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys 58:631–640
Schulz-Ertner D, Nikoghosyan A, Didinger B et al. (2004) Carbon ion radiation therapy for chordomas and low grade chondrosarcomas--current status of the clinical trials at GSI. Radiother Oncol 73 [Suppl 2]:53–56
Interessenkonflikt:
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schulz-Ertner, D., Schuck, A. Strahlentherapie bei Knochentumoren. Onkologe 12, 158–166 (2006). https://doi.org/10.1007/s00761-005-1006-2
Issue Date:
DOI: https://doi.org/10.1007/s00761-005-1006-2